drugset / Trial / NCT05044364

Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency

NCT05044364

Phase 3 Unknown 10 enrolled Shenzhen People's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Emergency treatment warning of clevidipine butyrate butyrate injection or invalid medical treatment and verification of the effectiveness and safety of subacute.

Timeline

Start
2021-10-11
Primary completion
2022-04-01
Completion
2022-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule Intravenous

Indications